Report Detail

Request for Sample of this report

Service & Software Global Multiparametric In-vitro Cardiotoxicity Testing Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4517816
    • |
  • 06 March, 2023
    • |
  • Global
    • |
  • 104 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Service & Software

According to our (Global Info Research) latest study, the global Multiparametric In-vitro Cardiotoxicity Testing market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Multiparametric In-vitro Cardiotoxicity Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type of Assay and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Multiparametric In-vitro Cardiotoxicity Testing market size and forecasts, in consumption value ($ Million), 2018-2029
Global Multiparametric In-vitro Cardiotoxicity Testing market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Multiparametric In-vitro Cardiotoxicity Testing market size and forecasts, by Type of Assay and by Application, in consumption value ($ Million), 2018-2029
Global Multiparametric In-vitro Cardiotoxicity Testing market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Multiparametric In-vitro Cardiotoxicity Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Multiparametric In-vitro Cardiotoxicity Testing market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Creative Bioarray, Agilent Technologies, Inc., Hemogenix Inc., Merck KGaA and Molecular Devices, LLC., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Multiparametric In-vitro Cardiotoxicity Testing market is split by Type of Assay and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type of Assay and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type of Assay
Calcium Transient Assay
Cardiac Marker Detection
hERG Assay
Multi-ion Channel Assay
Others
Market segment by Application
Contract Research Organizations (CROs)
Pharmaceutical and Biotech Companies
Others
Market segment by players, this report covers
Creative Bioarray
Agilent Technologies, Inc.
Hemogenix Inc.
Merck KGaA
Molecular Devices, LLC.
Miltenyi Biotec
FUJIFILM Cellular Dynamics
Enzo Life Sciences, Inc.
Axol Bioscience Ltd.
emka TECHNOLOGIES
Eurofins Discovery
Stemina Biomarker Discovery, Inc.
Evotec
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Multiparametric In-vitro Cardiotoxicity Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Multiparametric In-vitro Cardiotoxicity Testing, with revenue, gross margin and global market share of Multiparametric In-vitro Cardiotoxicity Testing from 2018 to 2023.
Chapter 3, the Multiparametric In-vitro Cardiotoxicity Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type of Assay and application, with consumption value and growth rate by Type of Assay, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Multiparametric In-vitro Cardiotoxicity Testing market forecast, by regions, type of assay and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Multiparametric In-vitro Cardiotoxicity Testing.
Chapter 13, to describe Multiparametric In-vitro Cardiotoxicity Testing research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Multiparametric In-vitro Cardiotoxicity Testing
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Multiparametric In-vitro Cardiotoxicity Testing by Type of Assay
    • 1.3.1 Overview: Global Multiparametric In-vitro Cardiotoxicity Testing Market Size by Type of Assay: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Multiparametric In-vitro Cardiotoxicity Testing Consumption Value Market Share by Type of Assay in 2022
    • 1.3.3 Calcium Transient Assay
    • 1.3.4 Cardiac Marker Detection
    • 1.3.5 hERG Assay
    • 1.3.6 Multi-ion Channel Assay
    • 1.3.7 Others
  • 1.4 Global Multiparametric In-vitro Cardiotoxicity Testing Market by Application
    • 1.4.1 Overview: Global Multiparametric In-vitro Cardiotoxicity Testing Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Contract Research Organizations (CROs)
    • 1.4.3 Pharmaceutical and Biotech Companies
    • 1.4.4 Others
  • 1.5 Global Multiparametric In-vitro Cardiotoxicity Testing Market Size & Forecast
  • 1.6 Global Multiparametric In-vitro Cardiotoxicity Testing Market Size and Forecast by Region
    • 1.6.1 Global Multiparametric In-vitro Cardiotoxicity Testing Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Multiparametric In-vitro Cardiotoxicity Testing Market Size by Region, (2018-2029)
    • 1.6.3 North America Multiparametric In-vitro Cardiotoxicity Testing Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Multiparametric In-vitro Cardiotoxicity Testing Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Multiparametric In-vitro Cardiotoxicity Testing Market Size and Prospect (2018-2029)
    • 1.6.6 South America Multiparametric In-vitro Cardiotoxicity Testing Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Multiparametric In-vitro Cardiotoxicity Testing Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Creative Bioarray
    • 2.1.1 Creative Bioarray Details
    • 2.1.2 Creative Bioarray Major Business
    • 2.1.3 Creative Bioarray Multiparametric In-vitro Cardiotoxicity Testing Product and Solutions
    • 2.1.4 Creative Bioarray Multiparametric In-vitro Cardiotoxicity Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Creative Bioarray Recent Developments and Future Plans
  • 2.2 Agilent Technologies, Inc.
    • 2.2.1 Agilent Technologies, Inc. Details
    • 2.2.2 Agilent Technologies, Inc. Major Business
    • 2.2.3 Agilent Technologies, Inc. Multiparametric In-vitro Cardiotoxicity Testing Product and Solutions
    • 2.2.4 Agilent Technologies, Inc. Multiparametric In-vitro Cardiotoxicity Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Agilent Technologies, Inc. Recent Developments and Future Plans
  • 2.3 Hemogenix Inc.
    • 2.3.1 Hemogenix Inc. Details
    • 2.3.2 Hemogenix Inc. Major Business
    • 2.3.3 Hemogenix Inc. Multiparametric In-vitro Cardiotoxicity Testing Product and Solutions
    • 2.3.4 Hemogenix Inc. Multiparametric In-vitro Cardiotoxicity Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Hemogenix Inc. Recent Developments and Future Plans
  • 2.4 Merck KGaA
    • 2.4.1 Merck KGaA Details
    • 2.4.2 Merck KGaA Major Business
    • 2.4.3 Merck KGaA Multiparametric In-vitro Cardiotoxicity Testing Product and Solutions
    • 2.4.4 Merck KGaA Multiparametric In-vitro Cardiotoxicity Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Merck KGaA Recent Developments and Future Plans
  • 2.5 Molecular Devices, LLC.
    • 2.5.1 Molecular Devices, LLC. Details
    • 2.5.2 Molecular Devices, LLC. Major Business
    • 2.5.3 Molecular Devices, LLC. Multiparametric In-vitro Cardiotoxicity Testing Product and Solutions
    • 2.5.4 Molecular Devices, LLC. Multiparametric In-vitro Cardiotoxicity Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Molecular Devices, LLC. Recent Developments and Future Plans
  • 2.6 Miltenyi Biotec
    • 2.6.1 Miltenyi Biotec Details
    • 2.6.2 Miltenyi Biotec Major Business
    • 2.6.3 Miltenyi Biotec Multiparametric In-vitro Cardiotoxicity Testing Product and Solutions
    • 2.6.4 Miltenyi Biotec Multiparametric In-vitro Cardiotoxicity Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Miltenyi Biotec Recent Developments and Future Plans
  • 2.7 FUJIFILM Cellular Dynamics
    • 2.7.1 FUJIFILM Cellular Dynamics Details
    • 2.7.2 FUJIFILM Cellular Dynamics Major Business
    • 2.7.3 FUJIFILM Cellular Dynamics Multiparametric In-vitro Cardiotoxicity Testing Product and Solutions
    • 2.7.4 FUJIFILM Cellular Dynamics Multiparametric In-vitro Cardiotoxicity Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 FUJIFILM Cellular Dynamics Recent Developments and Future Plans
  • 2.8 Enzo Life Sciences, Inc.
    • 2.8.1 Enzo Life Sciences, Inc. Details
    • 2.8.2 Enzo Life Sciences, Inc. Major Business
    • 2.8.3 Enzo Life Sciences, Inc. Multiparametric In-vitro Cardiotoxicity Testing Product and Solutions
    • 2.8.4 Enzo Life Sciences, Inc. Multiparametric In-vitro Cardiotoxicity Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Enzo Life Sciences, Inc. Recent Developments and Future Plans
  • 2.9 Axol Bioscience Ltd.
    • 2.9.1 Axol Bioscience Ltd. Details
    • 2.9.2 Axol Bioscience Ltd. Major Business
    • 2.9.3 Axol Bioscience Ltd. Multiparametric In-vitro Cardiotoxicity Testing Product and Solutions
    • 2.9.4 Axol Bioscience Ltd. Multiparametric In-vitro Cardiotoxicity Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Axol Bioscience Ltd. Recent Developments and Future Plans
  • 2.10 emka TECHNOLOGIES
    • 2.10.1 emka TECHNOLOGIES Details
    • 2.10.2 emka TECHNOLOGIES Major Business
    • 2.10.3 emka TECHNOLOGIES Multiparametric In-vitro Cardiotoxicity Testing Product and Solutions
    • 2.10.4 emka TECHNOLOGIES Multiparametric In-vitro Cardiotoxicity Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 emka TECHNOLOGIES Recent Developments and Future Plans
  • 2.11 Eurofins Discovery
    • 2.11.1 Eurofins Discovery Details
    • 2.11.2 Eurofins Discovery Major Business
    • 2.11.3 Eurofins Discovery Multiparametric In-vitro Cardiotoxicity Testing Product and Solutions
    • 2.11.4 Eurofins Discovery Multiparametric In-vitro Cardiotoxicity Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Eurofins Discovery Recent Developments and Future Plans
  • 2.12 Stemina Biomarker Discovery, Inc.
    • 2.12.1 Stemina Biomarker Discovery, Inc. Details
    • 2.12.2 Stemina Biomarker Discovery, Inc. Major Business
    • 2.12.3 Stemina Biomarker Discovery, Inc. Multiparametric In-vitro Cardiotoxicity Testing Product and Solutions
    • 2.12.4 Stemina Biomarker Discovery, Inc. Multiparametric In-vitro Cardiotoxicity Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Stemina Biomarker Discovery, Inc. Recent Developments and Future Plans
  • 2.13 Evotec
    • 2.13.1 Evotec Details
    • 2.13.2 Evotec Major Business
    • 2.13.3 Evotec Multiparametric In-vitro Cardiotoxicity Testing Product and Solutions
    • 2.13.4 Evotec Multiparametric In-vitro Cardiotoxicity Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Evotec Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Multiparametric In-vitro Cardiotoxicity Testing Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Multiparametric In-vitro Cardiotoxicity Testing by Company Revenue
    • 3.2.2 Top 3 Multiparametric In-vitro Cardiotoxicity Testing Players Market Share in 2022
    • 3.2.3 Top 6 Multiparametric In-vitro Cardiotoxicity Testing Players Market Share in 2022
  • 3.3 Multiparametric In-vitro Cardiotoxicity Testing Market: Overall Company Footprint Analysis
    • 3.3.1 Multiparametric In-vitro Cardiotoxicity Testing Market: Region Footprint
    • 3.3.2 Multiparametric In-vitro Cardiotoxicity Testing Market: Company Product Type Footprint
    • 3.3.3 Multiparametric In-vitro Cardiotoxicity Testing Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type of Assay

  • 4.1 Global Multiparametric In-vitro Cardiotoxicity Testing Consumption Value and Market Share by Type of Assay (2018-2023)
  • 4.2 Global Multiparametric In-vitro Cardiotoxicity Testing Market Forecast by Type of Assay (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Multiparametric In-vitro Cardiotoxicity Testing Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Multiparametric In-vitro Cardiotoxicity Testing Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Multiparametric In-vitro Cardiotoxicity Testing Consumption Value by Type of Assay (2018-2029)
  • 6.2 North America Multiparametric In-vitro Cardiotoxicity Testing Consumption Value by Application (2018-2029)
  • 6.3 North America Multiparametric In-vitro Cardiotoxicity Testing Market Size by Country
    • 6.3.1 North America Multiparametric In-vitro Cardiotoxicity Testing Consumption Value by Country (2018-2029)
    • 6.3.2 United States Multiparametric In-vitro Cardiotoxicity Testing Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Multiparametric In-vitro Cardiotoxicity Testing Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Multiparametric In-vitro Cardiotoxicity Testing Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Multiparametric In-vitro Cardiotoxicity Testing Consumption Value by Type of Assay (2018-2029)
  • 7.2 Europe Multiparametric In-vitro Cardiotoxicity Testing Consumption Value by Application (2018-2029)
  • 7.3 Europe Multiparametric In-vitro Cardiotoxicity Testing Market Size by Country
    • 7.3.1 Europe Multiparametric In-vitro Cardiotoxicity Testing Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Multiparametric In-vitro Cardiotoxicity Testing Market Size and Forecast (2018-2029)
    • 7.3.3 France Multiparametric In-vitro Cardiotoxicity Testing Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Multiparametric In-vitro Cardiotoxicity Testing Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Multiparametric In-vitro Cardiotoxicity Testing Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Multiparametric In-vitro Cardiotoxicity Testing Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Multiparametric In-vitro Cardiotoxicity Testing Consumption Value by Type of Assay (2018-2029)
  • 8.2 Asia-Pacific Multiparametric In-vitro Cardiotoxicity Testing Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Multiparametric In-vitro Cardiotoxicity Testing Market Size by Region
    • 8.3.1 Asia-Pacific Multiparametric In-vitro Cardiotoxicity Testing Consumption Value by Region (2018-2029)
    • 8.3.2 China Multiparametric In-vitro Cardiotoxicity Testing Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Multiparametric In-vitro Cardiotoxicity Testing Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Multiparametric In-vitro Cardiotoxicity Testing Market Size and Forecast (2018-2029)
    • 8.3.5 India Multiparametric In-vitro Cardiotoxicity Testing Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Multiparametric In-vitro Cardiotoxicity Testing Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Multiparametric In-vitro Cardiotoxicity Testing Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Multiparametric In-vitro Cardiotoxicity Testing Consumption Value by Type of Assay (2018-2029)
  • 9.2 South America Multiparametric In-vitro Cardiotoxicity Testing Consumption Value by Application (2018-2029)
  • 9.3 South America Multiparametric In-vitro Cardiotoxicity Testing Market Size by Country
    • 9.3.1 South America Multiparametric In-vitro Cardiotoxicity Testing Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Multiparametric In-vitro Cardiotoxicity Testing Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Multiparametric In-vitro Cardiotoxicity Testing Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Multiparametric In-vitro Cardiotoxicity Testing Consumption Value by Type of Assay (2018-2029)
  • 10.2 Middle East & Africa Multiparametric In-vitro Cardiotoxicity Testing Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Multiparametric In-vitro Cardiotoxicity Testing Market Size by Country
    • 10.3.1 Middle East & Africa Multiparametric In-vitro Cardiotoxicity Testing Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Multiparametric In-vitro Cardiotoxicity Testing Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Multiparametric In-vitro Cardiotoxicity Testing Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Multiparametric In-vitro Cardiotoxicity Testing Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Multiparametric In-vitro Cardiotoxicity Testing Market Drivers
  • 11.2 Multiparametric In-vitro Cardiotoxicity Testing Market Restraints
  • 11.3 Multiparametric In-vitro Cardiotoxicity Testing Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Multiparametric In-vitro Cardiotoxicity Testing Industry Chain
  • 12.2 Multiparametric In-vitro Cardiotoxicity Testing Upstream Analysis
  • 12.3 Multiparametric In-vitro Cardiotoxicity Testing Midstream Analysis
  • 12.4 Multiparametric In-vitro Cardiotoxicity Testing Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Multiparametric In-vitro Cardiotoxicity Testing. Industry analysis & Market Report on Multiparametric In-vitro Cardiotoxicity Testing is a syndicated market report, published as Global Multiparametric In-vitro Cardiotoxicity Testing Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Multiparametric In-vitro Cardiotoxicity Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,780.52
    		4,170.78
    		5,561.04
    		3,358.20
    		5,037.30
    		6,716.40
    		547,160.40
    		820,740.60
    		1,094,320.80
    		298,270.80
    		447,406.20
    		596,541.60
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo